8-KThe WireRoutine
Shareholder Vote
Filed Jun 10, 2019 · 7y ago · Accession 0001193125-19-169316
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Allogene Therapeutics, Inc.
- Ticker
- ALLO
- CIK
- 1737287
- Form type
- 8-K
- Filing date
- Jun 10, 2019
- Report date
- Jun 6, 2019
- Document
- d761662d8k.htm
- Size
- 23 KB